Mavacamten effectively reduces > 100 mmHg left ventricular outflow tract gradients As early as one week of treatment in obstructive hypertrophic cardiomyopathy

Hasonló tételek

• Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
  Szerző: Desai Milind Y, et al.
  Megjelent: (2025)
• Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy Exploratory Insights From the ODYSSEY-HCM Trial /
  Szerző: Desai Milind Y., et al.
  Megjelent: (2025)
• Characterisation of interrelations among myocardial work parameters in patients with hypertrophic cardiomyopathy differences between non-obstructive and obstructive disease /
  Szerző: Nagy Viktória, et al.
  Megjelent: (2026)
• Insight into pathogenesis of severe mitral valve regurgitation in a patient with obstructive hypertrophic cardiomyopathy [abstract] /
  Szerző: Ionica Loredana N., et al.
  Megjelent: (2022)
• Videodensitometric time-density curve change after alcohol septal ablation of obstructive hypertrophic cardiomyopathy
  Szerző: Nemes Attila, et al.
  Megjelent: (2015)